Health services experts Jeffrey Braithwaite and Russell Mannion doubt the value
Against the idea that publicly reported performance measurement, like apple pie, parenthood and the national flag, deserves a warm, uncritical glow of universal support should be roundly rejected. Introducing any costly new initiative must always be analysed with a cool head for its risks and potential downside. Where is the Australian business case, or the international cost–benefit analysis or cost-effectiveness analysis, applied to Australia, that compels us to not only accept, but insist on its introduction? These have not been provided by proponents to date.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1. Smith PC, Mossialos E, Papanicolas I, Leatherman S. Conclusions. In: Smith PC, Mossialos E, Papanicolas I, Leatherman S, editors. Performance measurement for health systems improvement: experiences, challenges and prospects. Cambridge: Cambridge University Press, 2009.
- 2. Iezzoni L, editor. Risk adjustment for measuring health care outcomes. 3rd ed. Chicago, Ill: Health Administration Press, 2003.
- 3. Hindle D, Braithwaite J, Iedema R, Travaglia, J. Patient safety: a comparative analysis of eight inquiries in six countries. Sydney: Centre for Clinical Governance Research, University of New South Wales, 2006.
- 4. Davies H, Mannion R. Clinical governance: striking a balance between checking and trusting. In: Smith P, editor. Reforming health care markets: An economic perspective. Buckingham: Open University Press; 2010: 247-267.
- 5. Mannion R, Goddard M. Impact of published clinical outcomes data: case study in NHS hospital trusts. BMJ 2001; 323: 260-263.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
None identified.